Earnings · China A-shares
Qianjiang Yongan Pharmaceutical Co., Ltd. Class A (002365) earnings
Qianjiang Yongan Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-29: net profit +348.81% year on year, +2009.75% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +7.91% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- +348.81%
- Excl. one-offs YoY
- +2009.75%
- Net profit QoQ
- +99.10%
- Result
- Great
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +9.98% | — |
| 3 days | +7.91% | — |
| 7 days | +9.08% | — |
| 14 days | +2.61% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 5 of 8 reports (average +0.21%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | ¥114.43M | +348.81% | +2009.75% | +64.38% | 0.40 | 5.59% | +7.91% | — | — |
| 2026 interim report | 2026-08-28 | ¥43.41M | +247.39% | +1622.35% | +53.44% | 0.15 | 2.16% | +5.76% | -19.75% | -10.05% |
| 2026 Q1 report | 2026-04-30 | ¥7.74M | +277.16% | +208.72% | +37.83% | 0.03 | 0.39% | +4.84% | -17.78% | -19.83% |
| 2025 annual report | 2026-04-17 | ¥22.49M | -63.58% | — | -6.63% | 0.08 | 1.13% | -4.47% | -16.11% | -20.09% |
| 2025 Q3 report | 2025-10-30 | ¥25.50M | -58.78% | -86.17% | -6.72% | 0.09 | 1.28% | +1.63% | -9.52% | -4.78% |
| 2025 interim report | 2025-08-28 | ¥12.50M | -76.19% | -93.65% | -13.72% | 0.04 | 0.63% | -3.21% | -2.53% | -8.03% |
| 2025 Q1 report | 2025-04-29 | -¥4.37M | -115.23% | — | -12.96% | -0.02 | -0.22% | -10.89% | +93.63% | +91.05% |
| 2024 annual report | 2025-04-10 | ¥61.77M | +601.65% | +135.21% | -13.78% | 0.21 | 3.11% | +0.10% | +120.33% | +114.73% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.